Related Experiment Video
Updated: Jan 4, 2026

14:51
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
3.5K
Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients
1Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Molecular & Cellular Oncology
|November 7, 2019
Abstract:
We recently identified three sub-populations of refractory acute myeloid leukemia (AML) patients with distinct intrinsic resistance mechanisms. Furthermore, we were able to risk-stratify the overall survival of the patients and identify patients who would likely benefit from alternative therapies.

